A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer

被引：0
|
作者：
Kyoung Ha Kim
Young Suk Park
Myung Hee Chang
Hyo Song Kim
Hyun Jung Jun
Jieun Uhm
Seong Yoon Yi
Do Hyoung Lim
Sang Hoon Ji
Min Jae Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Docetaxel; Oxaliplatin; Advanced gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 353
页数：6
相关论文
共 50 条
  • [31] A phase II study of bevacizumab, docetaxel, and oxaliplatin in gastric and GEJ cancer
    El-Rayes, B. F.
    Patel, B.
    Zalupski, M.
    Hammad, N.
    Shields, A.
    Heilbrun, L.
    Venkatramanamoorthy, R.
    Philip, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Phase II trial of weekly docetaxel/fluorouracil/cisplatin in patients with advanced gastric cancer: Preliminary results
    Evangelista, W.
    Racca, P.
    Fanchini, L.
    Ritorto, G.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Fusco, V
    Alabiso, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 48 - 48
  • [33] Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial
    Monti, Manlio
    Morgagni, Paolo
    Nanni, Oriana
    Framarini, Massimo
    Saragoni, Luca
    Marrelli, Daniele
    Roviello, Franco
    Petrioli, Roberto
    Romario, Uberto Fumagalli
    Rimassa, Lorenza
    Bozzarelli, Silvia
    Donini, Annibale
    Graziosi, Luigina
    De Angelis, Verena
    De Manzoni, Giovanni
    Bencivenga, Maria
    Mengardo, Valentina
    Parma, Emilio
    Milandri, Carlo
    Mura, Gianni
    Signorini, Alessandra
    Baiocchi, Gianluca
    Molfino, Sarah
    Sgroi, Giovanni
    Steccanella, Francesca
    Rausei, Stefano
    Proserpio, Ilaria
    Vigano, Jacopo
    Brugnatelli, Silvia
    Rinnovati, Andrea
    Santi, Stefano
    Ercolani, Giorgio
    Foca, Flavia
    Valmorri, Linda
    Amadori, Dino
    Frassineti, Giovanni Luca
    CANCERS, 2020, 12 (10) : 1 - 13
  • [34] Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02
    F. Rivera
    B. Massutí
    M. Salcedo
    J. Sastre
    J. Martínez Galán
    M. Valladares-Ayerbes
    R. Serrano
    Mª. L. García de Paredes
    J. L. Manzano
    M. Galán
    M. Alsina
    A. L. Yuste Izquierdo
    C. López
    E. Díaz-Rubio
    V. Conde
    M. Reboredo
    Mª. T. Cano
    V. Pachón
    E. Aranda
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 319 - 324
  • [35] Phase I/II trial of preoperative oxaliplatin, docetaxel, capecitabine, and radiation for localized esophageal cancer
    Meluch, A. A.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Farley, C.
    Peyton, J. D.
    Shipley, D. L.
    Steis, R. G.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] THE TEX REGIMEN (DOCETAXEL, OXALIPLATIN AND CAPECITABINE) IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL CANCER: RESULTS FROM A PHASE II TRIAL OF THE GERMAN AIO GROUP
    Thuss-Patience, P.
    Arnold, D.
    Stein, A.
    Grothe, W.
    Seufferlein, T.
    Reinacher-Schick, A.
    Geissler, M.
    Hofheinz, R.
    Moehler, M.
    Schmoll, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 90 - 90
  • [37] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [38] Pemetrexed plus oxaliplatin in the management of advanced gastric cancer:: A multicenter phase II trial
    Bajetta, Emilio
    Celio, Luigi
    Calabro, Fabio
    Mosconi, Stefania
    La Torre, Ignazia
    Barone, Carlo
    Berardi, Rossana
    Amoroso, Vito
    Pinotti, Graziella
    Di Costanzo, Francesco
    ANNALS OF ONCOLOGY, 2006, 17 : 313 - 313
  • [39] Phase I/II study of docetaxel plus FOLFOX in locally advanced or metastatic gastric cancer patients
    Filippelli, G.
    Lucia, M.
    La Gattuta, G.
    Caputo, A.
    Olivito, V
    Talarico, R.
    De Simone, R.
    Dima, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 28
  • [40] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Kim, Young Saing
    Sym, Sun Jin
    Park, Se Hoon
    Park, Inkeun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Woon Ki
    Chung, Min
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 163 - 169
12345